Join
Live feed
·
PRReleasevia Quantisnow
Allogene Therapeutics Inc. logo
Cellectis S.A. logo

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLO (Allogene Therapeutics Inc.), CLLS (Cellectis S.A.) and more on Quantisnow.